QNCX (Quince Therapeutics, Inc. Common Stock) Stock Analysis

Quince Therapeutics, Inc. Common Stock (QNCX) is a publicly traded Healthcare sector company. As of May 21, 2026, QNCX trades at $1.09 with a market cap of $16.22M and a P/E ratio of -0.64. QNCX moved +1.40% today. Year to date, QNCX is -96.22%; over the trailing twelve months it is -89.41%. Its 52-week range spans $0.79 to $45.50. Rallies surfaces QNCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest QNCX stock research?

Quince Therapeutics, Inc. Common Stock (QNCX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. QNCX moved +1.40% today.

QNCX Key Metrics

Key financial metrics for QNCX
MetricValue
Price$1.09
Market Cap$16.22M
P/E Ratio-0.64
EPS$-1.68
Dividend Yield0.00%
52-Week High$45.50
52-Week Low$0.79
Volume21.60K
Avg Volume0
Revenue (TTM)$0
Net Income$-80.77M
Gross Margin0.00%

Latest QNCX News

Recent QNCX Insider Trades

  • Benatti Luca sold 50.00K (~$173.50K) on Dec 26, 2025.
  • Thye Dirk bought 77.00K (~$53.90K) on Aug 30, 2024.
  • Thye Dirk bought 77.50K (~$53.47K) on Aug 29, 2024.

QNCX Analyst Consensus

QNCX analyst coverage data. Average price target: $0.00.

Common questions about QNCX

What can I research for QNCX on Rallies?
Quince Therapeutics, Inc. Common Stock (QNCX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. QNCX moved +1.40% today.
Does Rallies show live market data for QNCX?
Rallies combines live market context with ticker research for QNCX, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
QNCX

QNCX